Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: MIT Sloan School of Management
Originally published in: 2008
Version: 13 March 2008
Length: 30 pages
Data source: Field research
Notes: This item is part of a free case collection. For terms & conditions go to www.thecasecentre.org/freecaseterms

Abstract

Case describes changes facing the structure of the pharmaceutical industry as a result of new science and untenable cost structures and Eli Lilly's long-range strategy involving the development of tailored drugs. A follow on case to 'Lilly’s Project Resilience' (07-041), although it can also be taught as a stand alone case. Designed to explore the issues inherent in trying to implement a significantly different strategy without investing in significant organizational change. Explores the choices Lilly has made to invest in 'tailored therapeutics' and asks the students to consider whether they will lead to success. Can be taught in stratetgy and advanced strategy courses. This case is part of the MIT Sloan free case collection, click for more information.

About

Abstract

Case describes changes facing the structure of the pharmaceutical industry as a result of new science and untenable cost structures and Eli Lilly's long-range strategy involving the development of tailored drugs. A follow on case to 'Lilly’s Project Resilience' (07-041), although it can also be taught as a stand alone case. Designed to explore the issues inherent in trying to implement a significantly different strategy without investing in significant organizational change. Explores the choices Lilly has made to invest in 'tailored therapeutics' and asks the students to consider whether they will lead to success. Can be taught in stratetgy and advanced strategy courses. This case is part of the MIT Sloan free case collection, click for more information.

Related